ReviewDiagnostics (Basel, Switzerland)2026
Beyond One-Size-Fits-All Active Surveillance for Low-Risk Prostate Cancer: Risk-Adapted Follow-Up, De-Escalation Pathways, and Focal Therapy as Tailored Strategy.
Fabio Zattoni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.